Involved-field radiation therapy for selected cases of recurrent ovarian cancer.
Nalee KimJee Suk ChangSang-Wun KimGun Min KimJung-Yun LeeYong Bae KimPublished in: Journal of gynecologic oncology (2020)
Our early experience demonstrates the safety and feasibility of IFRT as an effective salvage therapy and enables a "chemotherapy holiday" in selected recurrent EOC settings. The CA-125 value before IFRT (within normal range) and/or platinum sensitivity could be used as selection criteria for IFRT.